Verapamil hcl vs. Losartan potassium and hydrochlorothiazide: side effect and effectiveness comparison (a real world drug study)

Summary:

We compare the side effects and drug effectiveness of Verapamil hcl and Losartan potassium and hydrochlorothiazide. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 87,283 people who take Verapamil hcl and Losartan potassium and hydrochlorothiazide, and is updated regularly.

What is Verapamil hcl?

Verapamil hcl has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,807 Verapamil hcl users. Check the latest studies of Verapamil hcl.

What is Losartan potassium and hydrochlorothiazide?

Losartan potassium and hydrochlorothiazide has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 2,184 Losartan potassium and hydrochlorothiazide users. Check the latest studies of Losartan potassium and hydrochlorothiazide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

87,283 people who take Verapamil hcl and Losartan potassium and hydrochlorothiazide are studied.

Verapamil hcl vs Losartan potassium and hydrochlorothiazide drug comparison reports.

Drugs being compared in this study:

  • Verapamil Hcl (verapamil hydrochloride)
  • Losartan Potassium And Hydrochlorothiazide (hydrochlorothiazide; losartan potassium)

Most common side effects of the drugs, overall:

Click here to view

Most common side effects of the drugs, in long term (1+ years) use:

Click here to view

Drug effectiveness:

Verapamil Hcl:

  • not at all: 2.91 %
  • somewhat: 20.21 %
  • moderate: 33.15 %
  • high: 31.09 %
  • very high: 12.63 %

Losartan Potassium And Hydrochlorothiazide:

  • not at all: 1.12 %
  • somewhat: 10.65 %
  • moderate: 30.09 %
  • high: 45.42 %
  • very high: 12.71 %

Want to compare Verapamil hcl with Losartan potassium and hydrochlorothiazide?

- Personalize this study to your gender and age (0-99+)

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies

Alternative drugs to, pros and cons of:

Browse all side effects of Verapamil hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Losartan potassium and hydrochlorothiazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study is based on verapamil hydrochloride and hydrochlorothiazide; losartan potassium (the active ingredients of Verapamil hcl and Losartan potassium and hydrochlorothiazide, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: